Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Elevated Risk for Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 0 results

Early research (Phase 1)Study completedNCT00118313
What this trial is testing

Vaccine Therapy With or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Craig L Slingluff, Jr
Not applicableLooking for participantsNCT05463796
What this trial is testing

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Who this might be right for
Cancer RiskCancer Predisposition SyndromeHereditary Cancer Prediction+28 more
Dana-Farber Cancer Institute 5,000
Early research (Phase 1)WithdrawnNCT06190249
What this trial is testing

Efficacy & Safety for LN144 With Pembrolizumab With High Risk Stage IIIb-dResectable Melanoma

Who this might be right for
Stage IIIB MelanomaStage IIIC MelanomaStage IIID Melanoma
James Isaacs, MD
Testing effectiveness (Phase 2)UnknownNCT00492505
What this trial is testing

Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III Melanoma

Who this might be right for
Melanoma (Skin)
San Diego Pacific Oncology & Hematology Associates 200
Testing effectiveness (Phase 2)Study completedNCT01079741
What this trial is testing

Safety Study of Adjuvant Vaccine to Treat Melanoma Patients

Who this might be right for
Melanoma
Nina Bhardwaj 34
Early research (Phase 1)Study completedNCT00003224
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
University of Virginia 22
Testing effectiveness (Phase 2)WithdrawnNCT00963664
What this trial is testing

Evaluation of Interferon-Lovastatin Therapy for Malignant Melanoma

Who this might be right for
MelanomaMalignant Melanoma
NeoPlas Innovation 250
Testing effectiveness (Phase 2)Active Not RecruitingNCT00539591
What this trial is testing

Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma

Who this might be right for
Malignant Melanoma
St. Jude Children's Research Hospital 29
Not applicableWithdrawnNCT00378781
What this trial is testing

Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection

Who this might be right for
Cancer
M.D. Anderson Cancer Center
Not applicableUnknownNCT05062096
What this trial is testing

Characterization of NK Cells Under First Line Advanced Therapy Either as Curative Therapy for Metastatic Melanoma or as Adjuvant Therapy for High-risk of Recurrence

Who this might be right for
Melanoma
Assistance Publique - Hôpitaux de Paris 220
Testing effectiveness (Phase 2)Ended earlyNCT04455503
What this trial is testing

Study of Adjuvant Immunotherapy With EVX-02 and Anti-PD-1

Who this might be right for
Melanoma Stage IVMelanoma Stage III
Evaxion Biotech A/S 15
Testing effectiveness (Phase 2)Study completedNCT00059475
What this trial is testing

Peptide Vaccination for Patients at High Risk for Recurrent Melanoma

Who this might be right for
Melanoma
National Cancer Institute (NCI) 138
Testing effectiveness (Phase 2)Looking for participantsNCT06365619
What this trial is testing

Neoadjuvant Ipilimumab/Nivolumab for Patients With Recurrent, High Risk, Resectable Melanoma

Who this might be right for
Melanoma
University of Utah 25
Large-scale testing (Phase 3)Active Not RecruitingNCT01274338
What this trial is testing

Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery

Who this might be right for
Melanoma of Unknown PrimaryRecurrent MelanomaStage IIIB Cutaneous Melanoma AJCC v7+2 more
National Cancer Institute (NCI) 1,673
Large-scale testing (Phase 3)Ended earlyNCT05665595
What this trial is testing

Adjuvant Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab for Resected High-Risk Melanoma in Participants With High-Risk Stage II-IV Melanoma (MK-7684A-010/KEYVIBE-010)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 1,594
Testing effectiveness (Phase 2)Study completedNCT00462280
What this trial is testing

Lovastatin in Treating Patients At High Risk of Melanoma

Who this might be right for
Precancerous ConditionStage 0 MelanomaStage I Melanoma+1 more
National Cancer Institute (NCI) 80
Large-scale testing (Phase 3)Ended earlyNCT04410445
What this trial is testing

Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence

Who this might be right for
MelanomaMelanoma Stage IIIMelanoma Stage IV+1 more
Nektar Therapeutics 765
Not applicableStudy completedNCT00912418
What this trial is testing

Pilot Study for the Evaluation of the Efficacy of Vaccination With Autologous Tumor Cells Plus Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) - in - Adjuvant, Followed by Systemic Low-dose-interleukin-2 (IL-2) Administration, in Patients With High Risk Melanoma

Who this might be right for
Melanoma
Craig L Slingluff, Jr 14
Not applicableUnknownNCT02907827
What this trial is testing

Whole-body DW-MRI and cfDNA Analysis for the Surveillance of Melanoma Patients at High Risk for Recurrence.

Who this might be right for
Melanoma
Universitair Ziekenhuis Brussel 100